HB Trademark

Trademark Overview


On Friday, June 7, 2019, a trademark application was filed for HB with the United States Patent and Trademark Office. The USPTO has given the HB trademark a serial number of 88464386. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 3, 2022. This trademark is owned by HEMISPHERX. The HB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
hb

General Information


Serial Number88464386
Word MarkHB
Filing DateFriday, June 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 3, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the letters "hb" in lower case letters with the letter "h" at the top and the letter "b" on the bottom sharing the end of the letter "h" slant to form the "b" inside of a slanted shaded square.
Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code042
First Use Anywhere DateMonday, June 5, 1995
First Use In Commerce DateMonday, June 5, 1995

Trademark Owner History


Party NameAIM IMMUNOTECH INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473

Party NameHEMISPHERX
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Party NameHEMISPHERX
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Trademark Events


Event DateEvent Description
Monday, January 3, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 3, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 3, 2021EXTENSION 3 GRANTED
Thursday, June 3, 2021EXTENSION 3 FILED
Thursday, June 3, 2021TEAS EXTENSION RECEIVED
Wednesday, December 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020EXTENSION 2 GRANTED
Monday, November 30, 2020EXTENSION 2 FILED
Monday, November 30, 2020TEAS EXTENSION RECEIVED
Friday, June 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 3, 2020EXTENSION 1 GRANTED
Wednesday, June 3, 2020EXTENSION 1 FILED
Wednesday, June 3, 2020TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 9, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Thursday, August 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, August 29, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 29, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, August 29, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 28, 2019ASSIGNED TO EXAMINER
Saturday, June 22, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 11, 2019NEW APPLICATION ENTERED IN TRAM